30 results
6-K
EX-99.1
GLPG
Galapagos NV
27 Oct 20
Current report (foreign)
12:13pm
EXHIBIT 99.1
Galapagos’ R&D Roundtable showcases Toledo program
Comprehensive preclinical package elucidates dual mode of action (MoA … -dependent dual MoA effect
Data package supports comprehensive clinical development of GLPG3970 in multiple Proof of Concept trials
Mechelen, Belgium; 27
6-K
EX-99.1
GLPG
Galapagos NV
11 Apr 22
Current report (foreign)
5:14pm
with ISS’ recommendation on this point.
The election of Paul as Director and his dual Chair/CEO role is a critical part of this powerful package
6-K
EX-99.2
GLPG
Galapagos NV
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
:
Qualifying Data Package
Schedule J:
Form of Security Agreement
Schedule 3.1(b):
Initial R&D Plan and Budget for Autotaxin Program
Schedule8.10-1 … Package has been delivered, in each case, for such Galapagos Program as further described in Sections 2.3(c) and 2.3(d).
Option, License and Collaboration
DRS/A
EX-10
GLPG
Galapagos NV
4 Mar 15
Draft registration statement (amended)
12:00am
(or region) on any other country (or region).
1.39 “Complete Data Package” has the meaning set forth in Section 3.1.4.
1.40 “Compound Failure” means … upon a container, wrapper, or any package insert utilized with or for such Licensed Product in such country or other jurisdiction.
1.149 “Product
6-K
GLPG
Galapagos NV
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
to determine the total remuneration package of the managing director (CEO) for his management function in the Company, it being understood
6-K
EX-99.1
0q5f k84s
7 Jan 19
Fibrocor and Galapagos sign partnership in fibrosis
7:48am
6-K
EX-99.1
v5r tw3budzv8vphi6v2
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.1
cc9i3ei4lvsne
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.15
wajsr8nxapqo7ls
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
nne2j7f m7134obzr8g
6 May 19
Current report (foreign)
4:05pm
6-K
EX-99.2
dc2kugpndsc8j6kw 0f
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.2
v9yikf98
1 Apr 19
Current report (foreign)
12:00am
6-K
EX-99.1
95uh183vj9po8wlg
12 Dec 23
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
7:02am
6-K
EX-99.1
k9nyp6i1j67i 5h0
23 Feb 24
Galapagos announces full year 2023 results and outlook for 2024
6:41am
6-K
EX-99.3
wg46aqh4jdfp5kswhav
1 Apr 19
Current report (foreign)
12:00am
6-K
EX-99.2
9ingr 4a9gd
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.1
k2djpga
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
DRS
yw11 bdjch8mtvx2j
6 Feb 15
Draft registration statement
12:00am
6-K
EX-99.2
cnopd vja149
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm